SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-038935
Filing Date
2020-03-26
Accepted
2020-03-26 18:03:21
Documents
2
Period of Report
2020-03-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2013962d1_3.html 3  
1 OWNERSHIP DOCUMENT tm2013962d1_3.xml 3 1635
2 EXHIBIT 24 tm2013962d1_ex24.htm EX-24 10934
  Complete submission text file 0001104659-20-038935.txt   14097
Mailing Address C/O DUSA PHARMACEUTICALS INC 25 UPTON DR WILMINGTON MA 01887
Business Address
CHAKOUTIS PETER M (Reporting) CIK: 0001257798 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35853 | Film No.: 20747273

Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Issuer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus